Preclinical testing at The Ohio State University found Telomir-Zn inhibited growth of canine and human osteosarcoma cell lines, prompting the company to explore a possible in-vivo study in dogs with naturally occurring tumors.
|Articles|August 1, 2018
Pfizer Suspends Delivery of Injectable Opioids to Veterinary Customers
Author(s)American Veterinarian Staff
The company does not anticipate that it will resume sales of injectable opioids to the veterinary market until mid-2019.
Advertisement
Pfizer announced it has suspended the sale and delivery of injectable opioids to veterinary customers, effective immediately. The deferment is said to be in response to a supply shortage caused by multiple manufacturing problems.
Advertisement
“We value all customers and understand the importance of these medications, and regret the current need to prioritize shipments to hospital and surgical trading partners,” Pfizer spokesperson Steven Danehy told the
Pfizer halted veterinary sales in the second quarter of 2018 but has been grappling with a supply shortage since June 2017.
According to Danehy, Pfizer will not resume selling injectable opioids to the veterinary market until it has fully recovered from the shortage, which is not anticipated until the second quarter of 2019.
Initially, many in the veterinary community speculated that the shortage was connected to the opioid epidemic and was connected to the US Drug Enforcement Agency, which has adamantly denied the claim.
The FDA has also stated publicly that it has no plans to restrict the veterinary extralabel use of Schedule II opioids and, therefore, is not connected to the shortage or delay in providing veterinarians with access to the drugs.
Advertisement
Related to this article
Caroline Cox, LSW, MSW, and Erika Krick, VMD, DACVIM (Oncology), discuss the role of veterinary social workers in supporting clients, communicating with veterinary teams, and helping practices address the human side of veterinary care in this Q&A from an interview at the 2026 Fetch National Harbor Veterinary Conference.
After more than 20 years of work toward its first rhino birth, the Texas ranch has now welcomed 3 calves in 3 years.
Two notable pet-industry acquisitions closed in September. One bringing AI-powered clinical documentation into IDEXX's software ecosystem, the other marking the first acquisition for fresh-food brand The Farmer's Dog.
New leadership moves, recognition, and achievement.
In a keynote address at the 2026 Fetch National Harbor Veterinary Conference, Jessica Pritchard, VMD, MS, DACVIM (SAIM), shared research showing that many owners decline vaccines because they do not think their pet needs them, and discussed ways veterinary teams can address those concerns.
Alyssa Mages, BS, CVT, FVTE, outlines key considerations for veterinary technicians during triage, from rapid patient assessment and prioritization to client communication and team coordination, in this interview from the 2026 Fetch National Harbor Veterinary Conference.
In a session at the 2026 Fetch National Harbor Veterinary Conference, Nathanael Oster, VMD, MBA, walked attendees through the biology, diagnosis, and treatment of the flea tapeworm in dogs and cats, including why cats are affected more often than dogs.
Advertisement
Advertisement
Trending on dvm360
1
Why pet owners decline vaccines: Survey insights and strategies for navigating hesitancy
2
Recent acquisitions: IDEXX buys CoVet, The Farmer's Dog acquires Woof
3
Paws and profits: Schwarzman AMC names zoological department head, Mars names chief digital and information officer, and more updates
4
Good flea control is good tapeworm control, veterinarian tells Fetch attendees
5